Fig. 3From: 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principleROC analyses revealed an AUC of 0.9174 (95% CI 0.89–0.95) for [99mTc]Tc-PSMA-I&T (154 samples with tumor, 252 samples without tumor)Back to article page